InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lexeo Therapeutics, Inc.

LXEO Clue Score11
United States Fiscal year ends December CIK 0001907108 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Richard Nolan Townsend
10 Dec 2024
Chief Executive Officer
Sold after exercise
2,500
$8.20
$20.49K
Richard Nolan Townsend
11 Nov 2024
Chief Executive Officer
Sold after exercise
2,500
$7.82
$19.56K
Richard Nolan Townsend
10 Oct 2024
Chief Executive Officer
Sold after exercise
5,000
$8.10
$40.50K
Richard Nolan Townsend
10 Sep 2024
Chief Executive Officer
Sold after exercise
5,000
$10.65
$53.27K
Richard Nolan Townsend
12 Aug 2024
Chief Executive Officer
Sold after exercise
5,000
$11.53
$57.63K
Richard Nolan Townsend
10 Jul 2024
Chief Executive Officer
Sold after exercise
3,347
$16.85
$56.40K
Richard Nolan Townsend
10 Jul 2024
Chief Executive Officer
Sold after exercise
23,622
$16.45
$388.58K
Richard Nolan Townsend
10 Jun 2024
Chief Executive Officer
Sold after exercise
2,038
$18.18
$37.05K
Richard Nolan Townsend
10 Jun 2024
Chief Executive Officer
Sold after exercise
2,962
$17.29
$51.21K
Richard Nolan Townsend
13 May 2024
Chief Executive Officer
Sold after exercise
5,000
$13.22
$66.09K
Show all 56 transactions →

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 10
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 6,496,115
History held since 9 Nov 2023